Doctor profile · Federal record
Dr. Nishan Thapa, PA-C
Surgical Physician Assistant (CMS: Physician Assistant) · Corpus Christi, TX
- NPI 1043795016
- Accepts Medicare
- MIPS 95.8 / 100 · 2023
- 8 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
4141 S Staples St Ste 300
Corpus Christi, TX 784110002
(361) 882-5560
fax (361) 882-6011
Credentials & registration
- NPI registered
- September 2018 — 8 yrs on file
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 363AS0400X — NUCC code
- State license (1)
- Texas #PA12284
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1043795016. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,049
Distinct HCPCS
10
Medicare allowed
$235,389
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,983 | 275 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 783 | 441 | $74 | |
17000 |
Destruction of precancer skin growth, 1 growth | 590 | 347 | $39 | |
11102 |
Biopsy of related skin growth, first growth | 486 | 352 | $73 | |
11103 |
Biopsy of related skin growth, each additional growth | 313 | 169 | $41 | |
17110 |
Destruction of skin growth, 1-14 growths | 214 | 158 | $90 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 139 | 107 | $106 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 121 | 121 | $93 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 73 | 63 | $47 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 52 | 45 | $140 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 187. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$1,483
Transactions
82
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 19 | $302.41 | |
| ABBVIE INC. | 14 | $248.82 | |
| Amgen Inc. | 13 | $209.70 | |
| UCB, Inc. | 9 | $170.67 | |
| Lilly USA, LLC | 5 | $95.49 | |
| LEO Pharma Inc. | 3 | $77.36 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $75.69 | |
| GENZYME CORPORATION | 4 | $73.58 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $55.66 | |
| Arcutis Biotherapeutics, Inc. | 2 | $39.10 | |
| Dermavant Sciences, Inc. | 2 | $36.97 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34.74 | |
| Almirall LLC | 1 | $24.83 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $21.47 | |
| Incyte Corporation | 1 | $16.10 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
679
Patients
442
Total drug cost
$18,805
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 148 | 76 | $9,416 |
| Doxycycline Hyclate | Generic | 142 | 107 | $1,487 |
| Triamcinolone Acetonide | Generic | 85 | 67 | $1,309 |
| Hydrocortisone | Generic | 71 | 51 | $600 |
| Ketoconazole | Generic | 64 | 40 | $1,324 |
| Mupirocin | Generic | 47 | 41 | $406 |
| Econazole Nitrate | Generic | 25 | 0 | $684 |
| Fluorouracil | Generic | 25 | 24 | $2,098 |
| Clindamycin Phosphate | Generic | 16 | 0 | $450 |
| Fluocinolone Acetonide | Generic | 16 | 11 | $700 |
Frequently asked questions
What is Dr. Nishan Thapa's medical specialty?
Dr. Nishan Thapa practices Surgical Physician Assistant in Corpus Christi, TX.
Where does Dr. Nishan Thapa practice?
Dr. Nishan Thapa practices at 4141 S Staples St Ste 300, Corpus Christi, TX 784110002. Office phone: 3618825560.
What is Dr. Nishan Thapa's NPI?
Dr. Nishan Thapa's National Provider Identifier (NPI) is 1043795016, issued by NPPES.
Does Dr. Nishan Thapa accept Medicare assignment?
Yes. Dr. Nishan Thapa accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nishan Thapa commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.